Insider · CIK 0001230484

KENYON LAWRENCE A

Reports to the SEC for 5 companies · ISELIN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001230484

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-14	OTLKOutlook Therapeutics, Inc.P Purchase	Director, Chief Financial Officer	PPurchase	+101K sh	—	—	106,956
2026-08-14	OTLKOutlook Therapeutics, Inc. · Warrants (right to buy)P Purchase	Director, Chief Financial Officer	PPurchase	+101K sh	—	—	101,010
2026-07-21	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+210K sh	—	—	210,078
2024-09-26	OTLKOutlook Therapeutics, Inc.P Purchase	Director, Chief Financial Officer	PPurchase	+5,000 sh	$5.69	+$28.4K	5,946
2024-03-20	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+12.5K sh	—	—	12,500
2021-04-20	OTLKOutlook Therapeutics, Inc.P Purchase	Director, Chief Financial Officer	PPurchase	+10K sh	$1.83	+$18.3K	18,926
2020-10-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+3.67M sh	—	—	3,668,984
2020-07-17	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+450K sh	—	—	450,000
2020-03-19	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+216K sh	—	—	216,435
2019-09-18	OTLKOutlook Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−1,350 sh	$1.70	−$2,295	8,926
2019-09-18	OTLKOutlook Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−1,350 sh	$1.70	−$2,295	80,863
2019-09-12	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+450K sh	—	—	450,000
2019-02-19	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+800K sh	—	—	800,000
2019-02-07	OTLKOutlook Therapeutics, Inc.P Purchase	Director, Chief Financial Officer	PPurchase	+25K sh	$0.90	+$22.4K	82,213
2018-09-18	OTLKOutlook Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−10.1K sh	$0.87	−$8,807.2	57,213
2018-08-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+500K sh	—	—	500,000
2017-12-22	OTLKOutlook Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−26.2K sh	$1.13	−$29.6K	67,313
2016-12-21	OTLKOutlook Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+50K sh	—	—	93,478
2014-02-24	Arno Therapeutics, IncStock Option (right to buy)A Award	Chief Financial Officer	AAward	+223K sh	—	—	223,445
2012-07-23	TAMIR BIOTECHNOLOGY, INC.Common Stock (Right to Buy)A Award	President, CEO and CFO	AAward	+400K sh	—	—	400,000
2010-08-02	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	Former EVP and CFO	FTax Payment	−6,312 sh	$26.90	−$170K	14,337
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−700 sh	$25.19	−$17.6K	38,127
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−4,711 sh	$25.19	−$119K	33,416
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−500 sh	$25.20	−$12.6K	32,916
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−2,800 sh	$25.20	−$70.6K	30,116
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−2,700 sh	$25.20	−$68.1K	27,416
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−100 sh	$25.21	−$2,520.7	27,316
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−100 sh	$25.21	−$2,520.75	27,216
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−1,041 sh	$25.21	−$26.2K	26,175
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−200 sh	$25.21	−$5,043	25,975
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−200 sh	$25.22	−$5,043.4	25,775
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−3,426 sh	$25.22	−$86.4K	22,349
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−100 sh	$25.25	−$2,525	22,149
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−600 sh	$25.25	−$15.2K	21,549
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−400 sh	$25.26	−$10.1K	21,149
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−300 sh	$25.27	−$7,579.5	20,849
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−200 sh	$25.27	−$5,054	20,649
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.Common Stock, Option to BuyM Exercise/Conversion	Former EVP and CFO	MExercise/Conversion	−21.4K sh	—	—	64,319
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−100 sh	$25.24	−$2,524	22,249
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.M Exercise/Conversion	Former EVP and CFO	MExercise/Conversion	+21.4K sh	$13.06	+$280K	42,088
2010-03-03	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Former EVP and CFO	SSale	−3,261 sh	$25.18	−$82.1K	38,827
2010-01-08	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	Former EVP and CFO	FTax Payment	−897 sh	$25.88	−$23.2K	20,649
2010-01-04	PAR PHARMACEUTICAL COMPANIES, INC.A Award	Former EVP and CFO	AAward	+10.8K sh	—	—	21,546
2010-01-04	PAR PHARMACEUTICAL COMPANIES, INC.Common Stock, Option to BuyA Award	Former EVP and CFO	AAward	+21.7K sh	—	—	21,563
2010-01-04	PAR PHARMACEUTICAL COMPANIES, INC.Common Stock, Option to BuyA Award	Former EVP and CFO	AAward	+21.7K sh	—	—	21,653
2009-01-08	PAR PHARMACEUTICAL COMPANIES, INC.Common Stock, Option to BuyA Award	Former EVP and CFO	AAward	+85.8K sh	—	—	85,758
2009-01-08	PAR PHARMACEUTICAL COMPANIES, INC.A Award	Former EVP and CFO	AAward	+10.7K sh	—	—	10,720
2005-04-28	NEOPHARM INCCommonA Award	CFO and Secretary	AAward	+43.1K sh	$7.95	+$343K	43,100

Recent filings

Accepted (ET)
Aug 144
KENYON LAWRENCE A0001649989-26-000009
SEC(opens sec.gov)
Jul 234
KENYON LAWRENCE A0001649989-26-000007
SEC(opens sec.gov)
Sep 304
KENYON LAWRENCE A0001415889-24-024093
SEC(opens sec.gov)
Mar 224
KENYON LAWRENCE A0001415889-24-008974
SEC(opens sec.gov)
Apr 204
KENYON LAWRENCE A0001209191-21-027683
SEC(opens sec.gov)
Oct 54
KENYON LAWRENCE A0001209191-20-053875
SEC(opens sec.gov)
Jul 214
KENYON LAWRENCE A0001209191-20-043224
SEC(opens sec.gov)
Mar 204
KENYON LAWRENCE A0001209191-20-020512
SEC(opens sec.gov)
Oct 154/A
KENYON LAWRENCE A0001209191-19-053184
SEC(opens sec.gov)
Sep 234
KENYON LAWRENCE A0001209191-19-050468
SEC(opens sec.gov)
Sep 134
KENYON LAWRENCE A0001209191-19-049497
SEC(opens sec.gov)
Feb 194
KENYON LAWRENCE A0001209191-19-011378
SEC(opens sec.gov)
Feb 84
KENYON LAWRENCE A0001209191-19-008782
SEC(opens sec.gov)
Sep 184
KENYON LAWRENCE A0001209191-18-051494
SEC(opens sec.gov)
Aug 34
KENYON LAWRENCE A0001209191-18-045340
SEC(opens sec.gov)
Dec 264
KENYON LAWRENCE A0001209191-17-067229
SEC(opens sec.gov)
Dec 224
Oncobiologics, Inc.0001209191-16-156585
SEC(opens sec.gov)
Feb 264
Arno Therapeutics, Inc0000914190-14-000070
SEC(opens sec.gov)
Jul 254
Tamir Biotechnology, Inc.0001387131-12-002276
SEC(opens sec.gov)

Companies

Address

C/O OUTLOOK THERAPEUTICS, INC. 111 S. WOOD AVE, UNIT #100

ISELIN, NJ, 08830